The American Cancer Society recently updated its colorectal cancer screening guideline for the first time since 2018 by ...

ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.

The new study results could make Abbott, which has an agreement with Freenome to market the blood-based test, the dominant ...

Forbes contributors publish independent expert analyses and insights. Physician who writes about the rising rates of cancer in young adults. Colon cancer is a leading cause of cancer-related deaths.

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A blood test that accurately detects colon cancer in middle-aged and ...

One analyst called the insurer’s decision a “watershed moment” for liquid biopsy-based cancer screening and for the category ...

Forbes contributors publish independent expert analyses and insights. Physician who writes about the rising rates of cancer in young adults. And while colonoscopy remains the gold standard for ...

Stool-based screening for colorectal cancer may be sharper in women than in men, and the reason traces back to sex-specific ...

Colorectal cancer cases are rising among younger people, striking even folks without obvious risk factors. For nearly two decades, UC San Francisco Family Community Medicine Professor Micheal Potter, ...

An experimental blood test can effectively and accurately detect colon cancer in middle-aged folks and seniors, a new study says. The research is published in the Journal of Clinical Oncology. The ...

A new blood test for colorectal cancer screening is being implemented in Alabama to improve early detection and reduce deaths from the disease.